Home

Shukra Pharmaceuticals PE Ratio

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

PE

81.6

Last updated on: Aug 16, 2025

Key Highlights

  • The P/E Ratio of Shukra Pharmaceuticals Ltd is 81.6 as of 16 Aug 9.00 AM .
  • The P/E Ratio of Shukra Pharmaceuticals Ltd changed from 203.3 on March 2020 to 19.3 on March 2024 . This represents a CAGR of -37.56% over 5 years.
  • The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 17.95 as of 14 Aug 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 39.8 in 5 years. This represents a CAGR of 13.53%.
  • The PE Ratio of Automobile industry is 21.5. The PE Ratio of Finance industry is 19.2. The PE Ratio of IT - Software industry is 26.8. The PE Ratio of Pharmaceuticals industry is 32.7. The PE Ratio of Retail industry is 102.8. The PE Ratio of Textiles industry is 52.5 in 2025.

Historical P/E Ratio of Shukra Pharmaceuticals Ltd

No data available

Company Fundamentals for Shukra Pharmaceuticals Ltd

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

Share Price

₹ 17.95

-0.36 (-1.97%)

stock direction

Last updated on: Aug 14, 2025

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Aug 202517.95
13 Aug 202518.31
12 Aug 202518.68
11 Aug 202518.36
08 Aug 202518.73
07 Aug 202519.11
06 Aug 202519.49
05 Aug 202519.88
04 Aug 202520.28
01 Aug 202520.69

SWOT Analysis Of Shukra Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Shukra Pharmaceuticals Ltd

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Shukra Pharmaceuticals Ltd785.99
Sun Pharmaceutical Industries Ltd394115
Divis Laboratories Ltd162735
Cipla Ltd126313
Torrent Pharmaceuticals Ltd122586
Dr Reddys Laboratories Ltd105095

PE Ratio of Shukra Pharmaceuticals Ltd Explained

785.99

Market cap

10

Earnings

81.6X

PE Ratio

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Shukra Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Shukra Pharmaceuticals Ltd

No data available

* All values are in %

About Shukra Pharmaceuticals Ltd

  • Shukra Pharmaceuticals Limited (Formerly known Relish Pharmaceuticals Limited) was established in March, 1993 and later on the Company name was changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on September 22, 2016.
  • The Company is presently engaged in the business of manufacturing and trading of pharmaceuticals formulations and laboratory testing. The company provides varieties of products to the clientele.
  • Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

Shukra Pharmaceuticals Ltd News Hub

Shukra Pharmaceuticals standalone net profit rises 16.67% in the June 2024 quarter

Net profit of Shukra Pharmaceuticals rose 16.67% to Rs 0.49 crore in the quarter ended June 2024 as

Read more

13 Aug 24

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 202

Read more

05 Aug 24

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company will be h

Read more

16 Sept 24

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 September

Read more

24 Sept 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions